We talked on the street outside ASCO GU 2023 with kidney cancer survivors and advocates Bryan Lewis and Howard McClurd of KidneyCan about how they helped raise $235 million in 6 years for kidney cancer research. KidneyCan runs the Kidney Cancer Advocacy Days, for which they encourage all stakeholders to join meetings in Washington, DC on March 13 and virtual meetings conducted via Zoom on March 14. Also, Michael Alchoueiry, MD (Brigham and Woman’s Hospital), talks about his work on the unique pathophysiology of chromophobe renal cell carcinoma, the unmet need in patients for targeted therapies, and about his group’s recent publication looking at ferroptosis as the potential Achilles heel for this type of tumor.
Let us know what you thought of this week’s episode on Twitter: @physicianswkly
Want to share your medical expertise, research, or unique experience in medicine on the PW podcast? Email us at email@example.com!
Thanks for listening!